Millipore Sigma Vibrant Logo

361549 GSK-3β Inhibitor VIII - CAS 487021-52-3 - Calbiochem

GSK-3β Inhibitor VIII, CAS 487021-52-3, is a cell-permeable, potent inhibitor of GSK-3 (IC50 = 104 nM). Inhibition is competitive with respect to ATP (Ki = 38 nM).

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: AR-A014418, N-(4-Methoxybenzyl)-Nʹ-(5-nitro-1,3-thiazol-2-yl)urea

Primary Target: Gsk-3β
View Products on Sigmaaldrich.com
361549
Voir les Prix & la Disponibilité

Aperçu

Replacement Information

Tableau de caractéristiques principal

CAS #Empirical Formula
487021-52-3C₁₂H₁₂N₄O₄S

Prix & Disponibilité

Référence DisponibilitéConditionnement Qté Prix Quantité
361549-5MG
Récupération des données relatives à la disponibilité...
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      		 Ampoule plast. 5 mg
      Prix en cours de récupération
      Le prix n'a pas pu être récupéré
      La quantité minimale doit être un multiple de
      Maximum Quantity is
      À la validation de la commande Plus d'informations
      Vous avez sauvegardé ()
       
      —
      Demander le prix
      		 —
      Description
      OverviewA cell-permeable thiazole-containing urea compound that acts as a potent inhibitor of GSK-3. Shown to inhibit GSK-3β with high potency (IC50 = 104 nM). Inhibition is competitive with respect to ATP (Ki = 38 nM). Specificity has been reported using a panel of 28 different kinases, including Cdk2 and Cdk5 (IC50 > 100 µM). Shown to prevent tau phosphorylation at a GSK-3-specific site. Also shown to protect neuronal cells against Aβ-mediated neurodegeneration in vitro and reduce tauopathy in mice in vivo (30 µmol/kg delivered with 40% PEG400 and 40% dimethylacetamide in water). Caution: Do not use delivering vehicles containing dimethylamine for in vivo studies, as it is highly toxic to animals. A 25 mM (5 mg/649 µl) solution of GSK-3β Inhibitor VIII (Cat. No. 361557) in DMSO is also available.
      Catalogue Number361549
      Brand Family Calbiochem®
      SynonymsAR-A014418, N-(4-Methoxybenzyl)-Nʹ-(5-nitro-1,3-thiazol-2-yl)urea
      References
      ReferencesNoble, W., et al. 2005. Proc. Natl. Acad. Sci. USA 102, 6990.
      Bhat, R., et al. 2003. J. Biol. Chem. 278, 45937.
      Product Information
      CAS number487021-52-3
      ATP CompetitiveY
      FormYellow solid
      Hill FormulaC₁₂H₁₂N₄O₄S
      Chemical formulaC₁₂H₁₂N₄O₄S
      HS Code2934 10 90
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      ApplicationGSK-3β Inhibitor VIII, CAS 487021-52-3, is a cell-permeable, potent inhibitor of GSK-3 (IC50 = 104 nM). Inhibition is competitive with respect to ATP (Ki = 38 nM).
      Biological Information
      Primary TargetGsk-3β
      Primary Target IC<sub>50</sub>104 nM against GSK-3β
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Carcinogenic / Teratogenic
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      361549-5MG 04055977214055

      Documentation

      GSK-3β Inhibitor VIII - CAS 487021-52-3 - Calbiochem FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      GSK-3β Inhibitor VIII - CAS 487021-52-3 - Calbiochem Certificats d'analyse

      TitreNuméro de lot
      361549

      Références bibliographiques

      Aperçu de la référence bibliographique
      Noble, W., et al. 2005. Proc. Natl. Acad. Sci. USA 102, 6990.
      Bhat, R., et al. 2003. J. Biol. Chem. 278, 45937.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision05-October-2007 JSW
      SynonymsAR-A014418, N-(4-Methoxybenzyl)-Nʹ-(5-nitro-1,3-thiazol-2-yl)urea
      DescriptionA cell-permeable, potent inhibitor of glycogen synthase kinase-3 (GSK-3). Shown to inhibit GSK-3β with high potency (IC50 = 104 nM). Inhibition is competitive with respect to ATP (Ki = 38 nM). Specificity has been reported using a panel of 28 different kinases, including Cdk2 and Cdk5 (IC50 >100 µM). Shown to prevent tau phosphorylation at a GSK-3-specific site. Also shown to protect neuronal cells against Aβ-mediated neurodegeneration in vitro and reduce tauopathy in mice in vivo (30 µmol/kg delivered with 40% PEG400 and 40% dimethylacetamide in water). Caution: Do not use delivering vehicles containing dimethylamine for in vivo studies, as it is highly toxic to animals.
      FormYellow solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number487021-52-3
      Chemical formulaC₁₂H₁₂N₄O₄S
      Structure formulaStructure formula
      Purity≥95% by HPLC
      SolubilityDMSO (5 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Carcinogenic / Teratogenic
      ReferencesNoble, W., et al. 2005. Proc. Natl. Acad. Sci. USA 102, 6990.
      Bhat, R., et al. 2003. J. Biol. Chem. 278, 45937.